**Core Concept**
The prognosis of Acute Lymphoblastic Leukemia (ALL) is influenced by various factors, including age, white blood cell count at diagnosis, and genetic abnormalities such as the Philadelphia chromosome. Understanding these factors is crucial for determining the optimal treatment strategy and predicting patient outcomes.

**Why the Correct Answer is Right**
The correct answer involves identifying factors associated with an unfavorable prognosis of ALL. A key factor is the presence of the Philadelphia chromosome, resulting from a t(9;22) translocation between the BCR and ABL1 genes. This genetic abnormality is associated with a poorer response to chemotherapy and a higher risk of relapse. Another factor is a high white blood cell count at diagnosis, which indicates a more aggressive disease.

**Why Each Wrong Option is Incorrect**
* **Option A:** **Age 50,000/μL** is a marker of a high-risk disease, but not the only factor influencing prognosis. A high WBC count at diagnosis indicates a more aggressive disease, but other factors such as the presence of the Philadelphia chromosome and specific genetic abnormalities also play a crucial role.

**Clinical Pearl / High-Yield Fact**
In pediatric ALL, the age of 1 year is a critical milestone for determining prognosis. Children under 1 year of age tend to have a favorable prognosis, while those over 1 year of age are at higher risk of relapse and require more intensive treatment.

**Correct Answer:** C.